{"id":"anti-arrhythmic-therapy","safety":{"commonSideEffects":[{"rate":"null","effect":"QT interval prolongation"},{"rate":"null","effect":"Torsades de pointes"}]},"_chembl":{"chemblId":"CHEMBL2108941","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Anti-arrhythmic drugs work by blocking potassium channels in the heart, which helps to regulate the heart's rhythm and prevent arrhythmias.","oneSentence":"Blocks potassium channels to prevent arrhythmias","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:52:40.892Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Supraventricular tachycardia"},{"name":"Ventricular tachycardia"},{"name":"Ventricular fibrillation"}]},"trialDetails":[{"nctId":"NCT06669299","phase":"NA","title":"Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-06-12","conditions":"Ventricular Tachycardia (VT)","enrollment":51},{"nctId":"NCT07487532","phase":"NA","title":"Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation (AF)","enrollment":120},{"nctId":"NCT05524077","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2020-07-08","conditions":"Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated","enrollment":162},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT04412096","phase":"PHASE4","title":"Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2020-11-23","conditions":"Glaucoma, OHT - Ocular Hypertension","enrollment":59},{"nctId":"NCT07447297","phase":"NA","title":"Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-01-02","conditions":"Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter","enrollment":520},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT06096337","phase":"NA","title":"Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2023-12-28","conditions":"Persistent Atrial Fibrillation","enrollment":484},{"nctId":"NCT06735534","phase":"NA","title":"Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System","status":"RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2025-06-03","conditions":"Persistent Atrial Fibrillation","enrollment":407},{"nctId":"NCT07424690","phase":"NA","title":"Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Karolinska University Hospital","startDate":"2026-05-20","conditions":"Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Elderly","enrollment":282},{"nctId":"NCT04239144","phase":"NA","title":"Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-11-09","conditions":"Chagas Cardiomyopathy, Ventricular Arrythmia","enrollment":45},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT05790707","phase":"NA","title":"EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment","status":"RECRUITING","sponsor":"Poitiers University Hospital","startDate":"2023-04-21","conditions":"Mild Cognitive Impairment, Persistent Atrial Fibrillation","enrollment":120},{"nctId":"NCT06842147","phase":"NA","title":"Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-03-01","conditions":"Atrial Fibrillation (AF)","enrollment":15360},{"nctId":"NCT07313605","phase":"PHASE1, PHASE2","title":"POCUS-Guided Esmolol in Septic Shock: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"John Basmaji","startDate":"2026-01-15","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06835491","phase":"PHASE3","title":"Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm","status":"RECRUITING","sponsor":"Versailles Hospital","startDate":"2025-11-06","conditions":"Ventricular Arrhythmias and Cardiac Arrest","enrollment":674},{"nctId":"NCT07254455","phase":"NA","title":"CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)","status":"NOT_YET_RECRUITING","sponsor":"Tulane University","startDate":"2026-03","conditions":"Atrial Fibrillation, Heart Failure With Preserved Ejection Fraction","enrollment":900},{"nctId":"NCT07119528","phase":"NA","title":"Application-Based Integrated Care in Patients After Pulse Field Ablation","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2025-07-21","conditions":"Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System","enrollment":500},{"nctId":"NCT04704050","phase":"PHASE4","title":"Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence","status":"TERMINATED","sponsor":"Tulane University School of Medicine","startDate":"2021-05-15","conditions":"Atrial Fibrillation, Atrial Fibrillation Recurrent","enrollment":22},{"nctId":"NCT03716934","phase":"PHASE4","title":"CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Hospital San Carlos, Madrid","startDate":"2018-06-27","conditions":"Atrial Fibrillation","enrollment":196},{"nctId":"NCT06434636","phase":"NA","title":"The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2024-12-01","conditions":"Middle Ear Disease","enrollment":100},{"nctId":"NCT06783868","phase":"","title":"Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-10","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT06553391","phase":"","title":"Heart Rhythm Changes in Patients With Atrial Fibrillation After Cardiopulmonary Bypass: a Retrospective Analysis","status":"COMPLETED","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2024-08-01","conditions":"Atrial Fibrillation","enrollment":106},{"nctId":"NCT05841056","phase":"PHASE3","title":"Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2024-06-13","conditions":"Atrial Fibrillation New Onset","enrollment":400},{"nctId":"NCT05596175","phase":"NA","title":"Super-Rehab: a Novel Approach to Treat Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal United Hospitals Bath NHS Foundation Trust","startDate":"2023-04-03","conditions":"Atrial Fibrillation, Overweight and Obesity","enrollment":36},{"nctId":"NCT05631730","phase":"PHASE3","title":"Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2023-01-04","conditions":"Mitral Valve Prolapse, Ventricular Arrhythmias and Cardiac Arrest","enrollment":50},{"nctId":"NCT07077811","phase":"NA","title":"The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.","status":"ENROLLING_BY_INVITATION","sponsor":"Affiliated Hospital of Nantong University","startDate":"2025-06-01","conditions":"Cardiovascular Diseases, Heart Failure, Atrial Fibrillation (AF)","enrollment":158},{"nctId":"NCT07034378","phase":"NA","title":"Comparison Between Extended Cryoablation, Standard Cryoablation, and Radiofrequency Ablation","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-09-28","conditions":"Atrial Fibrillation, Persistent","enrollment":288},{"nctId":"NCT03646357","phase":"PHASE4","title":"BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2018-10-01","conditions":"Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction","enrollment":2895},{"nctId":"NCT02686749","phase":"PHASE4","title":"Catheter Ablation vs. Medical Therapy in Congested Hearts With AF","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2016-06","conditions":"Congestive Heart Failure, Left Ventricular Failure, Atrial Fibrillation","enrollment":4},{"nctId":"NCT03376438","phase":"","title":"Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia","status":"COMPLETED","sponsor":"Edgar Jaeggi","startDate":"2017-06-08","conditions":"Atrial Flutter, Tachycardia, Supraventricular, Tachycardia, Atrial Ectopic","enrollment":330},{"nctId":"NCT06699342","phase":"NA","title":"Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-01-27","conditions":"Atrial Fibrillation (AF)","enrollment":50},{"nctId":"NCT06478667","phase":"PHASE3","title":"The Role of Levosimendan as Inotropic Agent in Acute Aluminum Phosphide-induced Cardiotoxicity","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-20","conditions":"Acute Myocarditis","enrollment":50},{"nctId":"NCT06322017","phase":"NA","title":"Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-09","conditions":"Atrial Fibrillation","enrollment":294},{"nctId":"NCT06418373","phase":"NA","title":"Development and Polit Study of Get Ready With my Heart Program","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2024-06-26","conditions":"Transition to Adult Care, Congenital Heart Disease","enrollment":30},{"nctId":"NCT06598280","phase":"NA","title":"Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2025-02-20","conditions":"Atrial Fibrillation","enrollment":270},{"nctId":"NCT06869083","phase":"NA","title":"Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2025-03","conditions":"Atrial Fibrillation on Apixaban Treatment","enrollment":5200},{"nctId":"NCT05594368","phase":"PHASE1","title":"Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2022-07-01","conditions":"Ventricular Tachycardia","enrollment":15},{"nctId":"NCT00540787","phase":"PHASE4","title":"A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Biosense Webster, Inc.","startDate":"2003-08-01","conditions":"Paroxysmal Atrial Fibrillation","enrollment":112},{"nctId":"NCT01803438","phase":"PHASE4","title":"Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Medtronic Cardiac Ablation Solutions","startDate":"2014-06","conditions":"Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases","enrollment":220},{"nctId":"NCT03118518","phase":"NA","title":"STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Medtronic Cardiac Ablation Solutions","startDate":"2017-06-23","conditions":"Atrial Fibrillation, Atrial Fibrillation New Onset","enrollment":225},{"nctId":"NCT01570361","phase":"PHASE4","title":"Atrial Fibrillation Progression Trial","status":"TERMINATED","sponsor":"Biosense Webster, Inc.","startDate":"2012-02-13","conditions":"Atrial Fibrillation","enrollment":255},{"nctId":"NCT00227344","phase":"PHASE4","title":"CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation","status":"TERMINATED","sponsor":"Biosense Webster EMEA","startDate":"2004-12","conditions":"Atrial Fibrillation","enrollment":129},{"nctId":"NCT00137540","phase":"PHASE3","title":"FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)","status":"COMPLETED","sponsor":"Biosense Webster EMEA","startDate":"2005-09","conditions":"Atrial Fibrillation","enrollment":40},{"nctId":"NCT03366181","phase":"","title":"SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2017-11-01","conditions":"Heart Failure, ICD, Diabetes Mellitus Type 2","enrollment":500},{"nctId":"NCT06730828","phase":"PHASE1, PHASE2","title":"Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects","status":"RECRUITING","sponsor":"Helios Cardio Inc.","startDate":"2024-12-16","conditions":"Atrial Fibrillation, Postoperative","enrollment":80},{"nctId":"NCT06645249","phase":"PHASE4","title":"Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Institut Investigacio Sanitaria Pere Virgili","startDate":"2024-12-10","conditions":"Atrial Fibrillation (AF)","enrollment":122},{"nctId":"NCT04037397","phase":"PHASE3","title":"First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-09-24","conditions":"Atrial Fibrillation","enrollment":25},{"nctId":"NCT05155865","phase":"NA","title":"Conduction System Pacing Versus Biventricular Pacing for Cardiac ResYNChronization","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2022-01-10","conditions":"Dilated Cardiomyopathy with Conduction Defect, Left Bundle-Branch Block, Heart Failure","enrollment":62},{"nctId":"NCT02913014","phase":"NA","title":"Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy","status":"COMPLETED","sponsor":"Prisma Health-Midlands","startDate":"2017-06-28","conditions":"Atrial Fibrillation","enrollment":50},{"nctId":"NCT06660134","phase":"NA","title":"Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF","status":"COMPLETED","sponsor":"Shanghai Chest Hospital","startDate":"2021-08-01","conditions":"Type 2 Diabetes Mellitus (T2DM), Atrial Fibrillation (AF)","enrollment":174},{"nctId":"NCT06632925","phase":"","title":"Utility of Analyzing Atrial Signal Electrograms in Patients with Atrial Fibrillation Using Next-Generation Ensite X Software: a Prospective Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2024-10-01","conditions":"Atrial Fibrillation (AF)","enrollment":80},{"nctId":"NCT02459574","phase":"NA","title":"Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-05-01","conditions":"Heart Failure, Recurrent Atrial Fibrillation","enrollment":321},{"nctId":"NCT06607471","phase":"","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","status":"RECRUITING","sponsor":"Scientific Institute San Raffaele","startDate":"2018-01-30","conditions":"Non-ischemic Cardiomyopathy, Dilated Cardiomyopathy (DCM), Hypertrophic Cardiomyopathy (HCM)","enrollment":15000},{"nctId":"NCT02830360","phase":"PHASE4","title":"Antiarrhythmics or Ablation for Ventricular Tachycardia 2","status":"COMPLETED","sponsor":"John Sapp","startDate":"2016-10","conditions":"Ventricular Tachycardia (VT)","enrollment":416},{"nctId":"NCT06455488","phase":"","title":"MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry","status":"RECRUITING","sponsor":"CorVita Science Foundation","startDate":"2020-07-20","conditions":"Ventricular Tachycardia","enrollment":130},{"nctId":"NCT06455020","phase":"NA","title":"Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2024-07-01","conditions":"Ventricular Tachycardia","enrollment":96},{"nctId":"NCT04160000","phase":"PHASE4","title":"Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure","status":"RECRUITING","sponsor":"Electrophysiology Research Foundation","startDate":"2020-07-26","conditions":"Atrial Fibrillation, Heart Failure, Diastolic Heart Failure","enrollment":360},{"nctId":"NCT04942834","phase":"NA","title":"Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2021-10-01","conditions":"Atrial Fibrillation, Persistent, Arrhythmias, Cardiac","enrollment":286},{"nctId":"NCT03561935","phase":"NA","title":"Beta-blocker vs. Ic Antiarrhythmic Drug for PVC","status":"WITHDRAWN","sponsor":"Yong Seog Oh","startDate":"2015-06","conditions":"Premature Ventricular Complex","enrollment":""},{"nctId":"NCT06272357","phase":"","title":"The Use of Antiarrhythmic Drugs in Pediatrics","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-04-01","conditions":"Antiarrhythmic Drug Adverse Reaction","enrollment":158},{"nctId":"NCT01013714","phase":"PHASE3","title":"Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias","status":"UNKNOWN","sponsor":"University of California, Los Angeles","startDate":"2021-07-26","conditions":"Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation","enrollment":40},{"nctId":"NCT03421834","phase":"NA","title":"Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2018-02-06","conditions":"Ventricular Tachycardia, Ischemic Cardiomyopathy","enrollment":60},{"nctId":"NCT05293080","phase":"PHASE3","title":"Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE","status":"NOT_YET_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2024-09","conditions":"Acute Ischemic Stroke, Atrial Fibrillation","enrollment":1746},{"nctId":"NCT06166524","phase":"PHASE2, PHASE3","title":"Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation","status":"UNKNOWN","sponsor":"Charles University, Czech Republic","startDate":"2024-01-01","conditions":"Atrial Fibrillation, Pulsed-field Ablation, Functional Exercise Testing","enrollment":124},{"nctId":"NCT03777631","phase":"PHASE3","title":"STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nippon Medical School","startDate":"2018-04-01","conditions":"Ischemic Stroke, Atrial Fibrillation Non-Rheumatic","enrollment":251},{"nctId":"NCT04011800","phase":"PHASE3","title":"PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.","status":"UNKNOWN","sponsor":"Charles University, Czech Republic","startDate":"2021-05-01","conditions":"Atrial Fibrillation","enrollment":212},{"nctId":"NCT02389218","phase":"PHASE4","title":"A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2015-03-03","conditions":"Atrial Fibrillation","enrollment":13},{"nctId":"NCT05939076","phase":"PHASE3","title":"First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Region Örebro County","startDate":"2023-08-21","conditions":"Atrial Fibrillation, Persistent","enrollment":220},{"nctId":"NCT03845010","phase":"NA","title":"Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment","status":"COMPLETED","sponsor":"Maatschap Cardiologie Zwolle","startDate":"2019-02-12","conditions":"Ventricular Premature Beats","enrollment":22},{"nctId":"NCT05364866","phase":"","title":"CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-05-01","conditions":"Cardiovascular Diseases","enrollment":200},{"nctId":"NCT03531502","phase":"NA","title":"Initial Management of Patients Receiving a Single Shock (IMPRESS)","status":"TERMINATED","sponsor":"Saint Luke's Health System","startDate":"2018-04-09","conditions":"Ventricular Tachycardia","enrollment":30},{"nctId":"NCT04004741","phase":"NA","title":"Effects of Osteopathic Manipulative Therapy on Arrhythmias","status":"COMPLETED","sponsor":"New York Institute of Technology","startDate":"2019-06-04","conditions":"Cardiac Arrhythmia","enrollment":42},{"nctId":"NCT05720572","phase":"PHASE4","title":"Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.","status":"UNKNOWN","sponsor":"Centre of Postgraduate Medical Education","startDate":"2019-09-01","conditions":"Atrial Fibrillation","enrollment":105},{"nctId":"NCT05641883","phase":"NA","title":"CardiaMend and Amiodarone for the Prevention of POAF","status":"UNKNOWN","sponsor":"Saint Alphonsus Regional Medical Center","startDate":"2023-01-01","conditions":"POAF, Atrial Fibrillation","enrollment":30},{"nctId":"NCT04208997","phase":"PHASE3","title":"Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-12-19","conditions":"Tachycardia, Ventricular, Catheter Ablation","enrollment":5},{"nctId":"NCT05514860","phase":"NA","title":"The Impact of \"First-Line\" Rhythm Therapy on AF Progression","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2017-01","conditions":"Atrial Fibrillation","enrollment":303},{"nctId":"NCT02825979","phase":"NA","title":"Early Aggressive Invasive Intervention for Atrial Fibrillation","status":"UNKNOWN","sponsor":"Jason Andrade","startDate":"2017-01","conditions":"Atrial Fibrillation","enrollment":303},{"nctId":"NCT03035227","phase":"PHASE4","title":"Catheter Ablation of Arrhythmias to Improve CRT Response","status":"TERMINATED","sponsor":"Kansas City Heart Rhythm Institute","startDate":"2017-01-23","conditions":"Arrhythmia, Cardiac","enrollment":2},{"nctId":"NCT03029169","phase":"PHASE4","title":"Propafenone Versus Amiodarone in Septic Shock","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2017-10-23","conditions":"Supraventricular Arrhythmia, Septic Shock","enrollment":210},{"nctId":"NCT03437356","phase":"NA","title":"Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drugs in Persistent Atrial Fibrillation","status":"COMPLETED","sponsor":"AZ Sint-Jan AV","startDate":"2018-02-26","conditions":"Atrial Fibrillation","enrollment":210},{"nctId":"NCT04724655","phase":"EARLY_PHASE1","title":"Paraffin Oil or Coconut Oil in Acute Aluminum Phosphide Poisoning","status":"COMPLETED","sponsor":"Tanta University","startDate":"2021-01-01","conditions":"Aluminum Phosphide Poisoning","enrollment":89},{"nctId":"NCT03590353","phase":"NA","title":"Effect of His Bundle Pacing in Treatment of Slow Arrhythmia on Function of Left Atrial and Ventricle","status":"COMPLETED","sponsor":"The Second Hospital of Hebei Medical University","startDate":"2018-06-01","conditions":"Slow Arrhythmia, His Bundle Pacing, Function of Left Atrial and Ventricle","enrollment":84},{"nctId":"NCT03517670","phase":"","title":"Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2020-08-31","conditions":"Cerebral Vasospasm, Subarachnoid Hemorrhage","enrollment":60},{"nctId":"NCT01416935","phase":"NA","title":"Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation","status":"TERMINATED","sponsor":"Inova Health Care Services","startDate":"2011-01-01","conditions":"Atrial Fibrillation","enrollment":186},{"nctId":"NCT02695992","phase":"PHASE4","title":"Rate Control in Atrial Fibrillation II","status":"COMPLETED","sponsor":"Asker & Baerum Hospital","startDate":"2016-02","conditions":"Atrial Fibrillation, Permanent Atrial Fibrillation","enrollment":122},{"nctId":"NCT04065893","phase":"","title":"Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy","status":"COMPLETED","sponsor":"Universitätsklinikum Köln","startDate":"2020-09-01","conditions":"Systolic Heart Failure, Ventricular Premature Complexes, Ventricular Tachycardia","enrollment":65},{"nctId":"NCT01420393","phase":"NA","title":"Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2011-09","conditions":"Heart Failure, Atrial Fibrillation","enrollment":411},{"nctId":"NCT05008250","phase":"PHASE4","title":"Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2014-01","conditions":"Premature Ventricular Contraction","enrollment":584},{"nctId":"NCT02924285","phase":"PHASE3","title":"Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease","status":"COMPLETED","sponsor":"University of Leipzig","startDate":"2017-11-01","conditions":"Heart Diseases, Cardiomyopathies, Ventricular Premature Complexes","enrollment":80},{"nctId":"NCT04942171","phase":"NA","title":"EMOTIon and COgNitive Function After Atrial Fibrillation Catheter Ablation vs. Medical Therapy(EMOTICON Trial)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2021-06","conditions":"Atrial Fibrillation","enrollment":320},{"nctId":"NCT04863001","phase":"","title":"Use of Antiarrhythmic Drugs in Pediatrics","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-10-01","conditions":"Antiarrhythmic Toxicity","enrollment":100},{"nctId":"NCT00911508","phase":"NA","title":"Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-11-13","conditions":"Atrial Fibrillation, Arrhythmia","enrollment":2204},{"nctId":"NCT03228823","phase":"PHASE4","title":"Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)","status":"UNKNOWN","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2018-08-01","conditions":"Ventricular Premature Beats, Contractions, or Systoles, Cardiomyopathies","enrollment":5},{"nctId":"NCT02341105","phase":"PHASE4","title":"AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation","status":"TERMINATED","sponsor":"Population Health Research Institute","startDate":"2016-01","conditions":"Atrial Fibrillation","enrollment":10},{"nctId":"NCT04128878","phase":"","title":"Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients","status":"COMPLETED","sponsor":"Samir Saba","startDate":"2019-05-01","conditions":"Atrial Fibrillation","enrollment":12},{"nctId":"NCT04702906","phase":"NA","title":"Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2021-02","conditions":"Aluminum Phosphide Poisoning","enrollment":40},{"nctId":"NCT04694092","phase":"NA","title":"Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation","status":"UNKNOWN","sponsor":"Institute for Clinical and Experimental Medicine","startDate":"2020-11-05","conditions":"Atrial Fibrillation, Atrial Fibrillation Rapid, Acute Heart Failure","enrollment":40},{"nctId":"NCT04495712","phase":"PHASE4","title":"Antiarrhythmic Effects of Spironolactone in Patients With ICDs","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2004-07-28","conditions":"Ventricular Arrhythmias","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":233,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amiodarone","Dronaderone","Sotalol","Beta blockers","Calcium channel blockers"],"phase":"phase_1","status":"active","brandName":"Anti-Arrhythmic therapy","genericName":"Anti-Arrhythmic therapy","companyName":"Imperial College London","companyId":"imperial-college-london","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Blocks potassium channels to prevent arrhythmias Used for Supraventricular tachycardia, Ventricular tachycardia, Ventricular fibrillation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}